tert-Butyl (4-hydroxypyridin-2-yl)carbamate

Catalog No. :
ACXVYU219
CAS No. :
937263-39-3
Molecular Formula :
C10H14N2O3
Molecular Weight :
210.23

IUPAC Name:tert-butyl (4-oxo-1,4-dihydropyridin-2-yl)carbamate

tert-Butyl (4-hydroxypyridin-2-yl)carbamate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$138.00Login to see priceIn stockInquiry
250mg95%$221.00Login to see priceIn stockInquiry
1g95%$452.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl (4-hydroxypyridin-2-yl)carbamate
IUPAC Nametert-butyl (4-oxo-1,4-dihydropyridin-2-yl)carbamate
MDL No.MFCD23378741
Molecular FormulaC10H14N2O3
Molecular Weight210.23
SMILESO=C(OC(C)(C)C)NC1=NC=CC(O)=C1
InChI KeyUXEXGQQHRWHRRM-UHFFFAOYSA-N
SynonymTERT-BUTYL 4-HYDROXYPYRIDIN-2-YLCARBAMATE;Carbamic acid, N-(4-hydroxy-2-pyridinyl)-, 1,1-dimethylethyl ester;tert-butyl N-(4-hydroxypyridin-2-yl)carbamate;tert-butyl N-(4-hydroxypyridin-2-yl)carbamate - [B87987]
CAS No.937263-39-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACXVYU219 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACXVYU219 route product structure diagram
    ACXVYU219937263-39-3 In Stock
Inquiry

2. ACXVYU219 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9 In Stock
  4. Plus
  5. reactant_3 route compound structure diagram
    --
  6. Then
  7. ACXVYU219 route product structure diagram
    ACXVYU219937263-39-3 In Stock
Inquiry

Comments (0)